Protein kinase A-independent cAMP stimulation of progesterone in a luteal cell model is tyrosine kinase dependent but phosphatidylinositol-3-kinase and mitogen-activated protein kinase independent

Biology of Reproduction

Volumn 77, Issue 1, 2007, Pages 147-155

  Needle, Elie ^a   Piparo, Kathy ^a,c   Cole, Donna ^a   Worrall, Carolyn ^a,c   Whitehead, Ian ^a   Mahon, Gwen ^a   Goldsmith, Laura T ^a,b  

^a University of Medicine and Dentistry of New Jersey ^*  (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

Corpus luteum; Corpus luteum function; Female reproductive tract; Progesterone; Signal transduction

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; GONADOTROPIN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; PROTEIN TYROSINE KINASE; RAS PROTEIN; SOMATOMEDIN C; STEROID HORMONE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HORMONE SYNTHESIS; IN VITRO STUDY; LUTEAL CELL; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE RELEASE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SECOND MESSENGER; STEROIDOGENESIS; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; CELL LINE; CORPUS LUTEUM; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; GENE EXPRESSION REGULATION; MITOGEN-ACTIVATED PROTEIN KINASES; PROGESTERONE; PROTEIN-TYROSINE KINASES; RATS;

MAMMALIA;

EID: 34250792735     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.106.053918     Document Type: Article

References (63)

1. Marsh JM, Savard K. The stimulation of progesterone synthesis in bovine corpora lutea by cAMP. Steroids 1966; 8:133-148.
2. Leung PK, Steele GL. Intracellular signaling in the gonads. Endocr Rev 1992; 13:476-498.
3. Steinkampf MP, Mendelson CR, Simpson ER. Effects of epidermal growth factor and insulin-like growth factor I on the levels of mRNA encoding aromatase cytochrome P-450 of human ovarian granulosa cells. Mol Cell Endocrinol 1988; 59:93-99.
4. McGee E, Sawetawan C, Bird I, Rainey WE, Carr BR. The effects of insulin on 3β-hydroxysteroid dehydrogenase expression in human luteinized granulosa cells. J Soc Gyn Invest 1995; 2:535-541.
5. Saragueta P, Krimer A, Charreau EH, Tesone M. Insulin regulation of steroidogenic activity in rat cultured luteal cells. Steroids Biochem 1989; 32:393-397.
6. Davoren JB, Hsueh A. Insulin enhances FSH-stimulated steroidogenesis by cultured rat granulosa cells. Mol Cell Endocrinol 1984; 35:97-105.
7. Adashi EY, Resnick CE, Svoboda ME, Vanwyk H. Somatomedin C synergizes with follicle-stimulating hormone in the acquisition of progestin biosynthetic capacity by cultured rat granulosa cells. Endocrinology 1985; 116:2135-2142.
8. DeMoura M, Choi DS, Adashi E, Payne D. Insulin-like growth factor-I-mediated amplification of follicle stimulating hormone-supported progesterone accumulation by cultured rat granulosa cells: enhancement of steroidogenic enzyme activity and expression. Biol Reprod 1997; 56:946-953.
9. Chakravorty A, Joslyn M, Davis J. Characterization of insulin and insulin-like growth factor-I actions in the bovine luteal cell: regulation of receptor tyrosine kinase activity, phosphatidylinositol-3-kinase, and deoxyribonucleic acid synthesis. Endocrinology 1993; 133:1331-1340.
10. Pescador N, Stocco D, Murphy B. Growth factor modulation of steroidogenic acute regulatory protein and luteinization in the pig ovary. Biol Reprod 1999; 60:1453-1461.
11. Acari P, Martinelli R, Salvatore F. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucl Acids Res 1984; 12:9179-9189.
12. Yun Tso J, Sun X-H, Kao T, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucl Acids Res 1985; 13:2485-2502.
13. Oonk RB, Parker KL, Gibson JL, Richards JS. Rat cholesterol side-chain cleavage cytochrome P-450 (P-450scc) gene. J Biol Chem 1990; 265:22392-22401.
14. Luu-The V, Lachance Y, Labrie C, Leblanc G, Thomas JL, Strickler RC, Labrie F. Full length cDNA structure and deduced amino acid sequence of human 3B-hydroxy-5-ene-steroid dehydrogenase. Mol Endocrinol 1989; 3:1310-1312.
15. Risk M, Shehu A, Mao J, Stocco CO, Goldsmith LT, Bowen-Shauver JM, Geula Gibori G. Characterization of a 5′ regulatory region of the prolactin receptor-associated protein/17 beta hydroxysteroid dehydrogenase 7 gene. Endocrinology 2005; 146:2807-2816.
16. Palejwala S, Stein DE, Weiss G, Monia BP, Tortoriello D, Goldsmith LT. Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology 2001; 142:3405-3413.
17. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
18. Chomczynski P. One-hour downward alkaline capillary transfer for blotting of DNA and RNA. Anal Biochem 1992; 201:134-139.
19. Palejwala S, Stein D, Wojtczuk A, Weiss G, Goldsmith LT. Demonstration of a relaxin receptor and relaxin-stimulated tyrosine phosphorylation in human lower uterine segment fibroblasts. Endocrinology 1998; 139:1208-1212.
20. Martel C, Labrie C, Couet J, Dupont E, Trudel C, Luu-The V, Takahashi M, Pelletier G, Labrie F. Effects of human chorionic gonadotropin and prolactin on 3 beta-hydroxy-5-ene-steroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) expression and activity in the rat ovary. Mol Cell Endocrinol 1990; 72:7-13.
21. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5- isoquinolinesulfonamide (H-89), of PC12 pheochromocytoma cells. J Biol Chem 1990; 265:5267-5272.
22. p)-cAMPS inhibits the cAMP-dependent protein kinase by blocking the cAMP-induced conformational transition. Fed Euro Biochem Soc 1995; 375:231-234.
23. Adashi EY, Resnick CE, Jastorff B. Blockade of granulosa cell differentiation by an antagonisitic analog of adenosine 3;5′-cyclic monophosphate (cAMP): central but non-exclusive intermediary role of cAMP in follicle-stimulation hormone action. Mol Cell Endocrinol 1990; 72:1-11.
24. p)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. J Biol Chem 1995; 270:20599-20607.
25. 2+-mobilizing signal mechanism. J Biol Chem 1995; 270:16082-16088.
26. Wang YF, Liu JW, Mamidi M, Walker AM. Identification of the major site of rat prolactin phosphorylation as serine 177. J Biol Chem 1996; 271:2462-2469.
27. Ruan Y, Kan H, Parmentier JH, Fatima S, Allen LF, Malik KU. Alpha-1A adrenergic receptor stimulation with phenylephrine promotes arachidonic acid release by activation of phospholipase D in Rat-1 fibroblasts: inhibition by protein kinase A. J Pharmacol Exp Ther 1998; 284:576-585.
28. Alesi D, Cuenda A, Cohen P, Dudley D, Saltiel A. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 1995; 270:27489-27494.
29. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998; 273:18623-18632.
30. Deregibus MC, Buttiglieri S, Russo S, Bussolati B, and Camussi G. CD40-dependent activation of phosphatidylinositol 3-kinase/akt pathway mediated endothelial cell survival and in vitro angiogenesis. J Biol Chem 2003; 278:18008-18014.
31. Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N, Murata Y. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 2001; 276:3459-3467.
32. Vlahos C, Matter W, Hui K, Brown R. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(-4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994; 269:5241-5248.
33. De Rooij J, Bos JL. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 1997; 14:623-625.
34. Van Triest M, De Rooij J, Bos JL. Measurement of GTP-bound Ras-like GTPases by activation-specific probes. Methods in Enzymology 2001; 333:343-348.
35. Cooke BA. Signal transduction involving cyclic AMP-dependent and cyclic AMP-independent mechanisms in the control of steroidogenesis. Mol Cell Endocrinol 1999; 151:25-35.
36. Richards JA. New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol Endocrinol 2001; 15:209-218.
37. Gonzalez-Robayna U, Falender AE, Ochsner S, Firestone GL, Richards JS. Follicle-stimulating hormone stimulates phosphorylation and activation of protein kinase B and serum and glucocorticoid-induced kinase: evidence for a kinase-independent signalling by FSH in granulosa cells. Mol Endocrinol 2000; 14:1283-1300.
38. Conti M. Specificity of the cyclic adenosine 3′,5′- monophosphate signal in granulosa cell function. Biol Reprod 2002; 67:1653-1661.
39. Morris JK, Richards JS. Hormone induction of luteinization and prostaglandin endoperoxide synthase-1 involves multiple cellular signaling pathways. Endocrinology 1993; 133:770-779.
40. Ding WQ, Dong M, Ninova D, Holicky EL, Stegall MD, Miller LJ. Forskolin suppresses insulin gene transcription in islet (3-cells through a protein kinase A-independent pathway. Cell Signal 2002; 15:27-35.
41. Hamelink C, Lee HW, Chen Y, Grimaldi M, Eiden LE. Coincident elevation of cAMP and calcium influx by PACAP-27 synergistically regulates vasoactive intestinal polypeptide gene transcription through a novel PKA-independent signaling pathway. J Neurosci 2002; 22:5310-5320.
42. Hecquet C, Lefevre G, Valtink M, Engelmann K, Mascarelli F. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner. Oncogene 2002; 21:6101-6112.
43. Kwon G, Pappan KL, Marshall CA, Schaffer JE, McDaniel ML. cAMP dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in β-cells. J Biol Chem 2004; 279:8938-8945.
44. Al-Alawi N, Rose DW, Buckmaster C, Ahn N, Rapp U, Meinkoth J, Feramisco JR. Thyrotropin-induced mitogenesis is Ras dependent but appears to bypass the Raf-dependent cytoplasmic kinase cascade. Mol Cell Biol 1995; 15:1162-1168.
45. Seger R, Tamar H, Rosenberg R, Dantes A, Merz WE, Strauss JF III, Amsterdam A. The ERK signaling cascade inhibits gonadotrophin-stimulated steroidogenesis. J Biol Chem 2001; 276:13957-13964.
46. deRooij J, Zwartkruis FJT, Verheijen MHG, Cool R, Nijman SMB, Wittinghofer A, Bos JL. Epac is a Rap1 guanint-nucleotide-exchange factor directly activated by cyclicAMP. Nature 1998; 396:474-477.
47. Pham N, Cheglakov I, Koch CA, De Hoog CL, Moran MF, Rotin D. The guanine nucleotide exchange factor CNrasGEF activates Ras in response to cAMP and cGMP. Curr Biol 2000; 10:555-558.
48. Pham N, Rotin D. Nedd4 regulates ubiquitination and stability of the guanine-nucleotide exchange factor CNrasGEF. J Biol Chem 2001; 276:46995-47003.
49. Palejwala S, Goldsmith LT. Ovarian expression of cellular Ki-ras p21 varies with physiological status. Proc Natl Acad Sci U S A 1992; 89:4202-4206.
50. Pan J, Roskelley C, Luu-The V, Rojiani M, Auersperg N. Reversal of divergent differentiation by ras oncogene-mediated transformation. Cancer Res 1992; 52:4269-4272.
51. Wiebe J, Myers K, Auersperg N. Modification of steroidogenesis in rat adrenocortical cells transformed by Kirsten Murine sarcoma virus. Cancer Res 1987; 47:1325-1332.
52. Pestell R, Albanese C, Watanabe G, Lee R, Lastowiecki P, Zon L, Ostrowski M, Jameson JL. Stimulation of the p-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways. Mol Endocrinol 1996; 10:1084-1094.
53. Hirakawa T, Ascoli M. The lutropin/choriogonadotropin receptor-induced phosphorylation of the extracellular signal-regulated kinases in leydig cells is mediated by a protein kinase a-dependent activation of Ras. Mol Endocrinol 2003; 17:2189-2200.
54. Tsygankova AM, Kupperman E, Wen W, Meinkoth JL. Cyclic AMP activates Ras. Oncogene 2000; 19:3609-3615.
55. Mor A, Philips MR. Compartmentalized Ras/MAPK signaling. Annu Rev Immunol 2006; 24:771-800.
56. Talavera F, Menon KMJ. Studies on rat luteal cell response to insulin-like growth factor I (IGF-I): identification of a specific cell membrane receptor for IGF-I in the luteinized rat ovary. Endocrinology 1991; 129:1340-1346.
57. Orly J, Rei Z, Greenberg NM, Richards JS. Tyrosine kinase inhibitor AG18 arrests follicle-stimulating hormone-induced granulosa cell differentiation: use of reverse transcriptase-polymerase chain reaction assay for multiple messenger ribonucleic acids. Endocrinology 1994; 143:2336-2346.
58. Orly J, Clemens J, Singer O, Richards JS. Effects of hormones and protein kinase inhibitors on expression of steroidogenic enzyme promoters in electroplated primary rat granulosa cells. Biol Reprod 1996; 54:208-218.
59. Gomberg-Malool S, Ziv R, Re'em Y, Posner I, Levitzki A, Orly J. Tyrphostins inhibit follicle-stimulating hormone-mediated functions in cultured rat ovarian granulosa cells. Endocrinology 1993; 132:362-370.
60. Baltensperger K, Lewis RE, Woon C-W, Vissavajjhala P, Ross AH, Czech MP. Catalysis of serine and tyrosine autophosphorylation by the human insulin receptor. Proc Natl Acad Sci U S A 1992; 89:7885-7889.
61. Saperstein R, Vicario PP, Strout HV, Brady E, Slater EE, Greenlee WJ, Ondeyka DL, Patchett AA, Hangauer DG. Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells. Biochemistry 1989; 28:5694-5701.
62. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995; 267:1782-1788.
63. Zhou Y, Brattain MG. Synergy of epidermal growth factor receptor kinase inhibitor AG1487 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis. Cancer Res 2005; 65:5848-5856.